PTC Therapeutics
Lara Sutton is a seasoned professional in pharmacovigilance with extensive experience in various leadership roles. Currently serving as Senior Director of G-QPPV at PTC Therapeutics, Inc. since July 2018, previous positions include Director of EU QPPV at the same company and Senior Manager of Pharmacovigilance at Regeneron Pharmaceuticals, Inc. Lara also held significant roles at QuintilesIMS, Acorn Regulatory, and Helsinn Group, showcasing a strong foundation in drug safety and regulatory affairs. Educational qualifications include a Specialist Diploma in Regulatory Affairs from the University of Limerick and a Master's degree in Pharmaceutical Medicine from Trinity College, Dublin.
This person is not in any teams
This person is not in any offices
PTC Therapeutics
11 followers
PTC is a science-driven, patient-centered biopharmaceutical company focused on discovering, developing & commercializing medicine for patients with rare disease.